These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8810302)

  • 21. Phenotypic characterization of a comprehensive set of bicyclomycin-resistant mutants.
    Moyse KA; Knight JS; Richardson JP
    Biochim Biophys Acta; 2001 Sep; 1520(3):223-33. PubMed ID: 11566358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bicyclomycin fluorescent probes: synthesis and biochemical, biophysical, and biological properties.
    Brogan AP; Widger WR; Kohn H
    J Org Chem; 2003 Jul; 68(14):5575-87. PubMed ID: 12839449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrophosphate inhibition of rho ATPase: a mechanism of coupling to RNA polymerase activity.
    Kent RB; Guterman SK
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):3992-6. PubMed ID: 6125940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rho-dependent termination and concomitant NTPase activity requires a specific, intact RNA region.
    Sharp JA; Platt T
    J Biol Chem; 1984 Feb; 259(4):2268-73. PubMed ID: 6199348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of E. coli rho factor: mutations affecting secondary-site interactions.
    Pereira S; Platt T
    J Mol Biol; 1995 Aug; 251(1):30-40. PubMed ID: 7643387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The attenuator of the tryptophan operon in E.coli: rho-mediated release of RNA polymerase from a transcription termination complex in vitro.
    Fuller RS; Platt T
    Nucleic Acids Res; 1978 Dec; 5(12):4613-23. PubMed ID: 370776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escherichia coli transcription termination factor rho. I. ATPase activation by oligonucleotide cofactors.
    Wang Y; von Hippel PH
    J Biol Chem; 1993 Jul; 268(19):13940-6. PubMed ID: 8314760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Termination factor Rho and its cofactors NusA and NusG silence foreign DNA in E. coli.
    Cardinale CJ; Washburn RS; Tadigotla VR; Brown LM; Gottesman ME; Nudler E
    Science; 2008 May; 320(5878):935-8. PubMed ID: 18487194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rho transcription factor: symmetry and binding of bicyclomycin.
    Vincent F; Openshaw M; Trautwein M; Gaskell SJ; Kohn H; Widger WR
    Biochemistry; 2000 Aug; 39(31):9077-83. PubMed ID: 10924100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the action of Escherichia coli transcription termination protein rho by poly(C) and heparin.
    Bektesh SL; Richardson JP
    Biochim Biophys Acta; 1981 Aug; 655(1):96-101. PubMed ID: 6114750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Large Insertion Domain in the Rho Factor From a Low G + C, Gram-negative Bacterium is Critical for RNA Binding and Transcription Termination Activity.
    Simon I; Delaleau M; Schwartz A; Boudvillain M
    J Mol Biol; 2021 Jul; 433(15):167060. PubMed ID: 34023400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mechanism of early transcription termination by Rho026.
    Washburn RS; Jin DJ; Stitt BL
    J Mol Biol; 1996 Jul; 260(3):347-58. PubMed ID: 8757798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATPase activity of transcription-termination factor rho: functional dimer model.
    Seifried SE; Easton JB; von Hippel PH
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10454-8. PubMed ID: 1438233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription Elongation Factor NusA Is a General Antagonist of Rho-dependent Termination in Escherichia coli.
    Qayyum MZ; Dey D; Sen R
    J Biol Chem; 2016 Apr; 291(15):8090-108. PubMed ID: 26872975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rho-dependent transcription termination: more questions than answers.
    Banerjee S; Chalissery J; Bandey I; Sen R
    J Microbiol; 2006 Feb; 44(1):11-22. PubMed ID: 16554712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of in vivo Rho-dependent transcription termination defects: evidence for kinetically controlled steps.
    Shashni R; Mishra S; Kalayani BS; Sen R
    Microbiology (Reading); 2012 Jun; 158(Pt 6):1468-1481. PubMed ID: 22442304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the C(1) Triol Group in Bicyclomycin: Synthesis and Biochemical and Biological Properties.
    Park Hg HG; Zhang X; Widger WR; Kohn H
    J Org Chem; 1996 Nov; 61(22):7750-7755. PubMed ID: 11667730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional dissections of transcription termination factor rho by random mutagenesis.
    Miwa Y; Horiguchi T; Shigesada K
    J Mol Biol; 1995 Dec; 254(5):815-37. PubMed ID: 7500353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of rho factor: an RNA-binding domain and a separate region with strong similarity to proven ATP-binding domains.
    Dombroski AJ; Platt T
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2538-42. PubMed ID: 2451828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription termination factor Rho is essential for Micrococcus luteus.
    Nowatzke WL; Keller E; Koch G; Richardson JP
    J Bacteriol; 1997 Aug; 179(16):5238-40. PubMed ID: 9260971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.